Multiplex Bead Array Technology is Ideal for Probing Mechanisms of Cancer Therapeutics

Following fast on the heels of last week’s publication that a multiplex bead array technique (AKA Bioplex) had been used to discover biomarkers that predict the onset of Rheumatoid Arthritis, a group in Germany has published a study using the same technology (BioPlex) to study the effects of ERBITUX sensitivity and resistance on cell surface receptor activation in certain cancer types.

The authors conclude that Bio-Plex phosphoprotein assays, in combination with Oncotest’s patient-derived tumor xenograft lysates, can be used by researchers to probe deeper into the mechanisms of cancer therapeutics.

The paper is definitely recommended for anyone involved in the field of biomarker research

Tags: , ,

Leave a Reply